Layn(002166)
Search documents
莱茵生物:关于参加投资者网上集体接待日活动的公告
2019-05-20 08:40
桂林莱茵生物科技股份有限公司 证券代码:002166 证券简称:莱茵生物 公告编号:2019-048 桂林莱茵生物科技股份有限公司 关于参加投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流,桂林莱茵生物科技股份有限公司(以下 简称"公司")将参加由广西上市公司协会、上证所信息网络有限公司、深圳市 全景网络有限公司共同举办的"2019 年广西地区上市公司投资者网上集体接待 日活动",现将有关事项公告如下: 本次集体接待日活动将通过深圳市全景网络有限公司提供的互联网平台举 行,投资者可以登陆"全景·路演天下"网站(http://rs.p5w.net)或关注微信 公众号:全景网路演天下(qj_lytx)参与公司本次投资者集体接待日活动,活动 时间为 2019 年 5 月 28 日(星期二)14:00 至 17:00。 届时,公司副总经理兼董事会秘书罗华阳先生将通过网络在线问答互动的形 式,与投资者就公司治理、发展经营情况、融资情况和可持续发展等投资者关注 的问题进行交流。期间,公司高管将全程在线,通过全景 ...
莱茵生物(002166) - 2019 Q1 - 季度财报
2019-04-28 16:00
桂林莱茵生物科技股份有限公司 2019 年第一季度报告全文 桂林莱茵生物科技股份有限公司 2019 年第一季度报告 2019 年 04 月 1 桂林莱茵生物科技股份有限公司 2019 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人秦本军、主管会计工作负责人郑辉及会计机构负责人(会计主管 人员)张为鹏声明:保证季度报告中财务报表的真实、准确、完整。 2 桂林莱茵生物科技股份有限公司 2019 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入(元) | 104,485,780.72 | 111,482,325.48 | -6.28% | | 归属于上市公司股东的净利润(元) | 10,709,457.75 | ...
莱茵生物(002166) - 2018 Q4 - 年度财报
2019-04-19 16:00
桂林莱茵生物科技股份有限公司 2018 年年度报告全文 桂林莱茵生物科技股份有限公司 2018 年年度报告 2019 年 04 月 1 桂林莱茵生物科技股份有限公司 2018 年年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连 带的法律责任。 公司负责人秦本军、主管会计工作负责人郑辉及会计机构负责人(会计主管 人员)张为鹏声明:保证年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中涉及公司未来计划等前瞻性陈述,公司声明该计划不构成公司对 投资者的实质承诺,请投资者及相关人士对此保持足够的风险认识,理解计划、 预测与承诺之间的差异。 本公司敬请广大投资者认真阅读本年度报告全文,并特别注意公司存在的 政策风险、宏观经济风险、市场风险、管理风险、原材料采购风险、汇率变动 风险等,详细内容见本年度报告"第四节 经营情况讨论与分析"之"九、公司未 来发展的展望"中阐述的公司可能面对的风险因素。 公司经本次董事会审议通过的利润分配预案为:公司拟以实施配 ...
莱茵生物(002166) - 2018 Q3 - 季度财报
2018-10-28 16:00
桂林莱茵生物科技股份有限公司 2018 年第三季度报告正文 证券代码:002166 证券简称:莱茵生物 公告编号:2018-066 桂林莱茵生物科技股份有限公司 2018 年第三季度报告正文 2018 年 10 月 1 桂林莱茵生物科技股份有限公司 2018 年第三季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人秦本军、主管会计工作负责人郑辉及会计机构负责人(会计主管 人员)张为鹏声明:保证季度报告中财务报表的真实、准确、完整。 2 桂林莱茵生物科技股份有限公司 2018 年第三季度报告正文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产(元) | 2,396,978,803.64 | | 2,896,950,51 ...
莱茵生物(002166) - 2018 Q2 - 季度财报
2018-08-26 16:00
[Section I Important Notice, Table of Contents, and Definitions](index=2&type=section&id=Section%20I%20Important%20Notice%2C%20Table%20of%20Contents%2C%20and%20Definitions) This section provides the important notice, table of contents, and definitions relevant to the semi-annual report - The company's board of directors, supervisory board, and senior management ensure the truthfulness, accuracy, and completeness of this semi-annual report and bear corresponding legal responsibilities[3](index=3&type=chunk) - Investors are reminded that forward-looking statements regarding future plans do not constitute substantial commitments, and attention should be paid to risks such as policy, macroeconomic, market, management, raw material, and exchange rate fluctuations[4](index=4&type=chunk) - The company's 2018 semi-annual profit distribution plan is to not distribute cash dividends, bonus shares, or convert capital reserves into share capital[5](index=5&type=chunk) [Section II Company Profile and Key Financial Indicators](index=6&type=section&id=Section%20II%20Company%20Profile%20and%20Key%20Financial%20Indicators) This section provides an overview of the company and its key financial performance during the reporting period [Key Accounting Data and Financial Indicators](index=7&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) In the first half of 2018, operating revenue decreased by **18.81%** due to the BT project nearing completion, while net profit attributable to shareholders increased by **1.26%**, and operating cash flow turned negative, with total assets declining by **9.89%** Key Financial Indicators for H1 2018 | Indicator | Current Period | Prior Period | YoY Change | | :--- | :--- | :--- | :--- | | Operating Revenue (RMB) | 307,180,652.21 | 378,352,935.18 | -18.81% | | Net Profit Attributable to Shareholders (RMB) | 72,266,618.07 | 71,365,258.46 | 1.26% | | Net Profit Attributable to Shareholders (Excluding Non-Recurring Items) (RMB) | 69,718,030.78 | 69,027,075.73 | 1.00% | | Net Cash Flow from Operating Activities (RMB) | -20,106,699.99 | 56,012,111.19 | -135.90% | | Basic Earnings Per Share (RMB/share) | 0.17 | 0.16 | 6.25% | | Total Assets (RMB) | 2,610,471,695.42 | 2,896,950,513.93 (Prior Year End) | -9.89% | | Net Assets Attributable to Shareholders (RMB) | 1,101,082,740.69 | 1,050,989,341.32 (Prior Year End) | 4.77% | - During the reporting period, total non-recurring gains and losses amounted to **RMB 2.5486 million**, primarily from government subsidies totaling **RMB 5.9256 million**[22](index=22&type=chunk)[23](index=23&type=chunk) [Section III Business Overview](index=9&type=section&id=Section%20III%20Business%20Overview) This section outlines the company's primary business operations, significant asset changes, and core competitive advantages [Primary Businesses During the Reporting Period](index=9&type=section&id=Primary%20Businesses%20During%20the%20Reporting%20Period) The company primarily operates in two segments: natural health products, focusing on natural sweeteners like Monk Fruit and Stevia extracts for food and beverage, and construction, mainly involving BT financing projects in Guilin, aiming for a full industry chain model - The company's main businesses are divided into two segments: natural health products (plant extraction and consumer goods) and construction (BT projects)[26](index=26&type=chunk)[27](index=27&type=chunk) Key Plant Extract Products and Applications | Product Name | Application Areas | | :--- | :--- | | Stevia Extract | Food, beverages, nutritional supplements, pharmaceuticals, etc | | Monk Fruit Extract | Food, beverages, nutritional supplements, pharmaceuticals, etc | | Shikimic Acid | Pharmaceutical field | | Rhodiola Extract | Nutritional supplements, cosmetics, pharmaceuticals, etc | | Grape Seed Extract | Nutritional supplements, cosmetics, etc | - The plant extraction business operates on a 'procurement + production + sales' model, consumer goods on a 'procurement + OEM + sales' model, and construction on a BT project model, with an overall strategy to build a full industry chain[28](index=28&type=chunk) [Significant Changes in Major Assets](index=10&type=section&id=Significant%20Changes%20in%20Major%20Assets) During the reporting period, major assets underwent significant changes, with long-term receivables and interest receivables decreasing by **100%** and **98.09%** respectively due to BT project repayments, cash decreasing by **41.50%** due to increased tax expenses, and other non-current assets increasing by **148.49%** for new factory equipment payments Major Asset Changes | Major Asset | Explanation of Change | | :--- | :--- | | Long-term Receivables | Decreased by 100% from the beginning of the period, due to repayment of BT project loans during the reporting period | | Cash and Cash Equivalents | Decreased by 41.50% from the beginning of the period, due to increased tax and fee expenses during the reporting period | | Other Non-current Assets | Increased by 148.49% from the beginning of the period, due to increased payments for new factory equipment during the reporting period | | Interest Receivables | Decreased by 98.09% from the beginning of the period, due to receipt of interest receivables accrued in prior years for BT projects during the reporting period | [Analysis of Core Competencies](index=11&type=section&id=Analysis%20of%20Core%20Competencies) The company's core competencies lie in scale, market channels, R&D, and quality control, with new factory operations enhancing capacity and environmental standards, a global sales network, 50 invention patents, and a full-chain quality control system including FDA GRAS certification for Monk Fruit and Stevia extracts - The company's core competencies remain unchanged, primarily in **scale, market channels, technology R&D, and quality control**[33](index=33&type=chunk) - The new factory is operational with an annual raw material processing capacity exceeding **60,000 tons**, implementing 'coal-to-gas' conversion and advanced wastewater treatment systems to promote a 'green circular economy'[33](index=33&type=chunk) - The company holds **50 invention patents** and has established multiple R&D platforms, including a 'Post-doctoral Research Workstation', demonstrating strong technological R&D capabilities[35](index=35&type=chunk) - The company is the world's first to simultaneously obtain US FDA GRAS certification for both Monk Fruit glycosides and Steviol glycosides, possessing a comprehensive quality certification system[36](index=36&type=chunk) [Section IV Management Discussion and Analysis](index=13&type=section&id=Section%20IV%20Management%20Discussion%20and%20Analysis) This section provides a comprehensive analysis of the company's operational performance, financial position, and future outlook [Overview](index=13&type=section&id=Overview) In H1 2018, operating revenue decreased by **18.81%** to **RMB 307 million** due to the BT business winding down, while net profit attributable to parent company shareholders increased by **1.26%** to **RMB 72.2666 million**, with plant extraction business, especially Stevia extract, showing stable growth and increased gross profit contribution - The plant extraction business developed steadily, with **Stevia extract** sales revenue and gross profit contribution significantly increasing, while Monk Fruit extract revenue slightly declined[39](index=39&type=chunk) - The BT business continued to advance, generating **RMB 138 million** in operating revenue and **RMB 62.8711 million** in net profit during the reporting period[40](index=40&type=chunk) - In the consumer goods segment, the company's self-developed botanical cosmetics, functional sugar-free gummies, and Monk Fruit flavored water beverages have been successively launched, with active expansion of online and offline sales channels[40](index=40&type=chunk) [Analysis of Main Business](index=14&type=section&id=Analysis%20of%20Main%20Business) During the reporting period, total operating revenue decreased by **18.81%** year-on-year, primarily due to a **36.05%** decline in construction (BT project) revenue, while manufacturing (plant extraction) revenue increased by **6.56%**, with construction gross margin rising to **54.95%** and manufacturing gross margin decreasing to **24.08%** Year-on-Year Changes in Key Financial Data | Item | Current Period (RMB) | Prior Period (RMB) | YoY Change | Reason for Change | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 307,180,652.21 | 378,352,935.18 | -18.81% | Reduced BT project workload | | Operating Cost | 190,248,955.12 | 256,633,417.88 | -25.87% | Reduced BT project revenue leading to corresponding cost reduction | | Selling Expenses | 14,880,157.87 | 10,807,649.11 | 37.68% | Increased expenses due to subsidiary staff expansion | | Financial Expenses | 6,110,937.86 | 10,688,157.80 | -42.83% | Reduced bank loans | | Net Cash Flow from Operating Activities | -20,106,699.99 | 56,012,111.19 | -135.90% | Increased tax and fee expenses | Operating Performance by Industry/Product | Category | Operating Revenue (RMB) | Operating Cost (RMB) | Gross Margin | YoY Change in Operating Revenue | | :--- | :--- | :--- | :--- | :--- | | Main Business - Manufacturing | 167,642,221.30 | 127,270,585.37 | 24.08% | 6.56% | | Main Business - Construction | 138,257,675.46 | 62,280,661.32 | 54.95% | -36.05% | [Analysis of Assets and Liabilities](index=16&type=section&id=Analysis%20of%20Assets%20and%20Liabilities) At the end of the reporting period, the asset structure significantly changed, with fixed assets increasing from **5.45%** to **21.34%** of total assets due to the transfer of construction in progress for the new factory, investment properties decreasing significantly due to transfer, and short-term borrowings decreasing from **18.28%** to **8.94%** of total assets Significant Changes in Asset Composition | Item | Proportion of Total Assets at Period End | Proportion of Total Assets at Prior Year End | Explanation of Change | | :--- | :--- | :--- | :--- | | Investment Properties | 0.22% | 9.13% | Due to the transfer of investment properties during the reporting period | | Fixed Assets | 21.34% | 5.45% | Due to the transfer of construction in progress for the new factory into fixed assets during the reporting period | | Construction in Progress | 0.10% | 14.01% | Due to the transfer of construction in progress for the new factory into fixed assets during the reporting period | | Short-term Borrowings | 8.94% | 18.28% | Due to a reduction in bank loans during the reporting period | - As of the end of the reporting period, **RMB 186 million** in assets were restricted, primarily fixed assets, intangible assets, and investment properties pledged for bank loans[53](index=53&type=chunk) [Analysis of Major Subsidiaries and Associates](index=18&type=section&id=Analysis%20of%20Major%20Subsidiaries%20and%20Associates) During the reporting period, Guilin Rhein Investment Co., Ltd., a subsidiary primarily engaged in BT projects, significantly impacted net profit with **RMB 62.8729 million** in H1 net profit, while Guilin Bank Co., Ltd., an associate, also had a notable impact, and Guilin Rhein Agricultural Development Co., Ltd. was newly established as a wholly-owned subsidiary Performance of Major Subsidiaries and Associates | Company Name | Type | Main Business | Net Profit (RMB) | | :--- | :--- | :--- | :--- | | Guilin Rhein Investment Co., Ltd. | Subsidiary | BT Projects | 62,872,937.04 | | Guilin Bank Co., Ltd. | Associate | Banking | 1,414,510,291 (Guilin Bank's own performance) | - During the reporting period, the company established a new wholly-owned subsidiary, 'Guilin Rhein Agricultural Development Co., Ltd.', which has been included in the consolidated financial statements[63](index=63&type=chunk) [Forecast of Operating Performance for Jan-Sep 2018](index=19&type=section&id=Forecast%20of%20Operating%20Performance%20for%20Jan-Sep%202018) The company forecasts net profit attributable to shareholders for Jan-Sep 2018 to range from **RMB 72 million** to **RMB 99 million**, a **-20% to 10%** change year-on-year, primarily due to increased plant extraction revenue offset by higher expenses and reduced BT project income Performance Forecast for Jan-Sep 2018 | Item | Forecast | | :--- | :--- | | YoY Change in Net Profit Attributable to Parent Company | -20% to 10% | | Net Profit Attributable to Parent Company Range | RMB 72 million to RMB 99 million | | Net Profit Attributable to Parent Company in Prior Period (2017) | RMB 89.9994 million | [Risks Faced by the Company and Countermeasures](index=19&type=section&id=Risks%20Faced%20by%20the%20Company%20and%20Countermeasures) The company faces six key risks: policy changes, macroeconomic shifts, market competition, management challenges from expansion, raw material supply volatility, and exchange rate fluctuations, addressed by monitoring policies, enhancing competitiveness, strengthening client relationships, implementing employee stock ownership plans, securing raw material supply, and expanding domestic markets - The company has identified six major risks: **policy risk, macroeconomic risk, market risk, management risk, raw material procurement risk, and exchange rate fluctuation risk**[65](index=65&type=chunk)[67](index=67&type=chunk)[68](index=68&type=chunk)[69](index=69&type=chunk)[71](index=71&type=chunk)[73](index=73&type=chunk) - To mitigate management risks, the company has launched **two phases of employee stock ownership plans**, covering middle and senior management and core employees to enhance cohesion and improve governance[70](index=70&type=chunk) - To ensure raw material supply, the company has established a 'company + base + farmers' cooperation model and plans to set up Monk Fruit and Stevia raw material planting bases to implement quality control from the source[72](index=72&type=chunk) [Section V Significant Events](index=22&type=section&id=Section%20V%20Significant%20Events) This section details significant events including litigation, employee incentive plans, and other major corporate actions [Litigation Matters](index=23&type=section&id=Litigation%20Matters) During the reporting period, the company was involved in a lawsuit with Shanghai Tongji Construction Co., Ltd. regarding a wastewater treatment plant construction contract, with the first-instance judgment requiring the company to pay **RMB 1.756 million**, which the company has appealed - The company is involved in a lawsuit with Shanghai Tongji Construction Co., Ltd. over a wastewater treatment plant construction contract, with a disputed amount of **RMB 5.559 million**; the first-instance court ruled the company pay **RMB 1.756 million**, and the company has appealed, with the case still ongoing[82](index=82&type=chunk)[83](index=83&type=chunk) [Implementation of Equity Incentive Plans, Employee Stock Ownership Plans, or Other Employee Incentive Measures](index=24&type=section&id=Implementation%20of%20Equity%20Incentive%20Plans%2C%20Employee%20Stock%20Ownership%20Plans%2C%20or%20Other%20Employee%20Incentive%20Measures) The company has implemented two phases of employee stock ownership plans, with the first phase (2016) having purchased **7.4987 million shares** and its lock-up period expired, and the second phase (2017) having purchased **9.6575 million shares** with its lock-up period expiring on September 16, 2018 - The company has launched **two phases of employee stock ownership plans**, with the lock-up period for the first phase expiring on March 30, 2017, and the second phase expiring on September 16, 2018[87](index=87&type=chunk)[88](index=88&type=chunk)[89](index=89&type=chunk) [Explanation of Other Significant Matters](index=29&type=section&id=Explanation%20of%20Other%20Significant%20Matters) The company is proceeding with a rights issue to all shareholders, with the public offering proposal approved by the general meeting on April 19, 2018, accepted by the CSRC on May 8, and feedback addressed by the end of the reporting period - The company plans a rights issue to all shareholders, which has been approved by the general meeting and accepted by the CSRC, and is currently in progress[108](index=108&type=chunk) [Section VI Changes in Shares and Shareholder Information](index=31&type=section&id=Section%20VI%20Changes%20in%20Shares%20and%20Shareholder%20Information) This section details changes in the company's share capital and the composition of its shareholders [Changes in Share Capital](index=31&type=section&id=Changes%20in%20Share%20Capital) During the reporting period, the company's total share capital of **437,281,362 shares** remained unchanged, but the share structure shifted as approximately **4.89 million restricted shares** from a non-public offering were released, reducing restricted shares from **20.20%** to **19.05%** of total shares - The **4,889,400 restricted shares** held by shareholder Yang Xiaotao from a non-public offering expired on April 30, 2018, leading to a reduction in the company's restricted shares[115](index=115&type=chunk) [Number of Shareholders and Shareholding Structure](index=32&type=section&id=Number%20of%20Shareholders%20and%20Shareholding%20Structure) As of the end of the reporting period, the company had **55,424 common shareholders**, with the actual controller Qin Benjun holding **17.57%** and forming a concerted party with Jiang Anming, Jiang Xiaosan, and Jiang Jun, while the first and second employee stock ownership plans ranked tenth and sixth among the top ten shareholders Top Ten Common Shareholders' Shareholding (As of Report End) | Shareholder Name | Shareholding Percentage | Number of Shares Held | | :--- | :--- | :--- | | Qin Benjun | 17.57% | 76,840,512 | | Yao Xinde | 7.86% | 34,361,643 | | Liang Dingzhi | 4.77% | 20,874,447 | | Central Huijin Asset Management Co., Ltd. | 4.46% | 19,491,600 | | Jiang Xiaosan | 3.19% | 13,969,226 | | Tibet Trust - Rhein No. 2 Collective Fund Trust Plan | 2.21% | 9,657,516 | | Yi Hongshi | 2.18% | 9,515,350 | | Jiang Anming | 2.13% | 9,304,728 | | Jiang Jun | 2.07% | 9,037,459 | | Caitong Securities Asset Management Rhein No. 1 Collective Asset Management Plan | 1.71% | 7,498,703 | - Shareholder Qin Benjun, Jiang Anming, Jiang Xiaosan, and Jiang Jun are brothers and constitute a concerted party[117](index=117&type=chunk) [Section VII Preferred Shares Information](index=34&type=section&id=Section%20VII%20Preferred%20Shares%20Information) This section confirms the absence of preferred shares during the reporting period [Preferred Shares](index=34&type=section&id=Preferred%20Shares) The company had no preferred shares during the reporting period - The company had no preferred shares during the reporting period[122](index=122&type=chunk) [Section VIII Information on Directors, Supervisors, and Senior Management](index=35&type=section&id=Section%20VIII%20Information%20on%20Directors%2C%20Supervisors%2C%20and%20Senior%20Management) This section confirms no changes in the shareholdings or composition of the company's directors, supervisors, and senior management [Changes in Directors, Supervisors, and Senior Management](index=35&type=section&id=Changes%20in%20Directors%2C%20Supervisors%2C%20and%20Senior%20Management) During the reporting period, there were no changes in the shareholdings or personnel of the company's directors, supervisors, and senior management - There were no changes in the shareholdings or personnel of the company's directors, supervisors, and senior management during the reporting period[124](index=124&type=chunk)[125](index=125&type=chunk) [Section IX Corporate Bonds Information](index=36&type=section&id=Section%20IX%20Corporate%20Bonds%20Information) This section confirms the absence of outstanding or defaulted corporate bonds during the reporting period [Corporate Bonds](index=36&type=section&id=Corporate%20Bonds) The company had no publicly issued and listed corporate bonds that were outstanding or fully defaulted as of the approval date of the semi-annual report - The company has no corporate bonds that are outstanding or have defaulted on full payment[128](index=128&type=chunk) [Section X Financial Report](index=37&type=section&id=Section%20X%20Financial%20Report) This section presents the company's unaudited financial statements, including balance sheets, income statements, cash flow statements, and notes [Audit Report](index=37&type=section&id=Audit%20Report) The company's 2018 semi-annual financial report is unaudited - The company's semi-annual financial report is unaudited[130](index=130&type=chunk) [Financial Statements](index=37&type=section&id=Financial%20Statements) This chapter presents the company's consolidated and parent company balance sheets, income statements, cash flow statements, and statements of changes in owner's equity for H1 2018, showing total assets of **RMB 2.61 billion**, total liabilities of **RMB 1.509 billion**, and net profit of **RMB 72.26 million** Key Items from Consolidated Balance Sheet (Period-End Balance) | Item | Amount (RMB) | | :--- | :--- | | Total Assets | 2,610,471,695.42 | | Total Liabilities | 1,509,365,818.33 | | Total Equity Attributable to Parent Company Owners | 1,101,082,740.69 | Key Items from Consolidated Income Statement (Current Period) | Item | Amount (RMB) | | :--- | :--- | | Total Operating Revenue | 307,180,652.21 | | Total Profit | 78,767,362.39 | | Net Profit | 72,259,947.88 | | Net Profit Attributable to Parent Company Owners | 72,266,618.07 | [Notes to Consolidated Financial Statements](index=76&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) This chapter provides detailed explanations of consolidated financial statement items, including accounts receivable of **RMB 83.56 million**, inventory book value of **RMB 1.589 billion** (with **RMB 1.18 billion** from BT projects), short-term borrowings of **RMB 233 million**, and prepayments of **RMB 720 million** (mainly for BT projects), with total operating revenue of **RMB 306 million** - Period-end inventory book value was **RMB 1.589 billion**, with **RMB 1.18 billion** attributed to construction in progress (BT projects), representing the most significant component of inventory[283](index=283&type=chunk) - Period-end prepayments amounted to **RMB 720 million**, of which **RMB 710 million** was for BT project construction payments[326](index=326&type=chunk) Revenue and Cost by Business Segment | Item | Revenue (RMB) | Cost (RMB) | | :--- | :--- | :--- | | Plant Extraction | 168,804,127.19 | 127,947,651.36 | | BT Projects | 138,337,897.67 | 62,280,661.32 | [Section XI Documents for Reference](index=116&type=section&id=Section%20XI%20Documents%20for%20Reference) This section lists the documents available for reference, including signed financial statements and publicly disclosed reports - Documents for reference include financial statements signed and sealed by the legal representative, chief financial officer, and head of accounting, the original 2018 semi-annual report signed by the company's legal representative, and the originals of all publicly disclosed documents and announcements during the reporting period[462](index=462&type=chunk)
莱茵生物(002166) - 2018 Q1 - 季度财报
2018-04-26 16:00
[Important Notice](index=2&type=section&id=Item%20I.%20Important%20Notice) The company's board of directors, supervisory board, and senior management guarantee the truthfulness, accuracy, and completeness of this quarterly report, with key executives also affirming the financial statements [Board Statement](index=2&type=section&id=Board%20Statement) The company's board of directors, supervisory board, and all senior executives guarantee the truthfulness, accuracy, and completeness of this quarterly report and assume corresponding legal responsibilities, with all directors attending the board meeting to review the report and key executives assuring the financial statements' integrity - The company's board of directors, supervisory board, directors, supervisors, and senior management guarantee the quarterly report's content is true, accurate, and complete, free from false records, misleading statements, or major omissions, and assume legal responsibility[4](index=4&type=chunk) - Company principal Qin Benjun, head of accounting Zheng Hui, and head of accounting department Zhang Weipeng declare and guarantee the truthfulness, accuracy, and completeness of the financial statements in the quarterly report[5](index=5&type=chunk) [Company Overview](index=3&type=section&id=Item%20II.%20Company%20Overview) This section provides key financial performance indicators for Q1 2018, including revenue, net profit, and cash flow, alongside detailed information on the company's shareholder structure [Key Accounting Data and Financial Indicators](index=3&type=section&id=II.%20I.%20Key%20Accounting%20Data%20and%20Financial%20Indicators) In Q1 2018, the company's operating revenue was **111.48 million yuan**, a **21.94% year-on-year decrease**, while net profit attributable to shareholders increased by **41.09% to 18.29 million yuan**, and net cash flow from operating activities significantly improved by **110.44% to 12.80 million yuan** 2018 Q1 Key Financial Data | Indicator | Current Period | Prior Year Period | Change from Prior Year Period | | :--- | :--- | :--- | :--- | | Operating Revenue (yuan) | 111,482,325.48 | 142,814,856.38 | -21.94% | | Net Profit Attributable to Shareholders (yuan) | 18,291,677.28 | 12,964,570.20 | 41.09% | | Net Cash Flow from Operating Activities (yuan) | 12,804,279.37 | -122,622,744.92 | 110.44% | | Basic Earnings Per Share (yuan/share) | 0.04 | 0.03 | 33.33% | | Weighted Average Return on Net Assets | 1.73% | 1.52% | 0.21% | | **Indicator** | **End of Current Period** | **End of Prior Year** | **Change from End of Prior Year** | | Total Assets (yuan) | 2,903,601,137.93 | 2,896,950,513.93 | 0.23% | | Net Assets Attributable to Shareholders (yuan) | 1,067,630,812.99 | 1,050,989,341.32 | 1.58% | - Total non-recurring gains and losses for the reporting period amounted to **448,519.67 yuan**, primarily from government subsidies[9](index=9&type=chunk) [Shareholder Information](index=4&type=section&id=II.%20II.%20Total%20Shareholders%20and%20Top%20Ten%20Shareholders%20at%20Period-End) As of the end of the reporting period, the company had **58,026 common shareholders**, with controlling shareholder Qin Benjun holding **17.57%** and acting in concert with Jiang Xiaosan, Jiang Anming, and Jiang Jun, while the top ten shareholders also include Central Huijin and two employee stock ownership plans - As of the end of the reporting period, the company had **58,026 common shareholders**[11](index=11&type=chunk) Top 10 Shareholders' Holdings | Shareholder Name | Shareholder Type | Holding Percentage | Number of Shares Held | Pledged Shares | | :--- | :--- | :--- | :--- | :--- | | Qin Benjun | Domestic Natural Person | 17.57% | 76,840,512 | 40,820,000 | | Yao Xinde | Domestic Natural Person | 7.86% | 34,361,643 | 34,361,459 | | Liang Dingzhi | Domestic Natural Person | 4.77% | 20,874,447 | - | | Central Huijin Asset Management Co., Ltd. | State-owned Legal Person | 4.46% | 19,491,600 | - | | Jiang Xiaosan | Domestic Natural Person | 3.19% | 13,969,226 | - | | Yi Hongshi | Domestic Natural Person | 2.32% | 10,139,300 | - | | Tibet Trust - Rhein No. 2 Collective Fund Trust Plan | Other | 2.21% | 9,657,516 | - | | Jiang Anming | Domestic Natural Person | 2.13% | 9,304,728 | - | | Jiang Jun | Domestic Natural Person | 2.07% | 9,037,459 | - | | Caitong Securities Asset Management - Rhein No. 1 Collective Asset Management Plan | Other | 1.71% | 7,498,703 | - | - Shareholders Qin Benjun, Jiang Xiaosan, Jiang Anming, and Jiang Jun are siblings and constitute parties acting in concert; Rhein No. 1 and No. 2 Trust Plans are the company's first and second employee stock ownership plans, respectively[12](index=12&type=chunk) [Significant Matters](index=6&type=section&id=Item%20III.%20Significant%20Matters) This section details the analysis of significant changes in financial data, progress on major projects like the BT project and rights issue, the half-year performance forecast, and other compliance-related disclosures [Analysis of Financial Data Changes](index=6&type=section&id=III.%20I.%20Changes%20and%20Reasons%20for%20Key%20Financial%20Data%20and%20Indicators%20in%20the%20Reporting%20Period) During the reporting period, several financial indicators changed significantly, with operating revenue decreasing by **21.94%** due to reduced BT project and plant extraction business income, while operating costs saw a larger **34.78%** decrease primarily due to improved BT project gross margin, and operating cash flow significantly improved due to **145 million yuan** in BT project repayments Balance Sheet Key Item Changes and Reasons | Item | Change Percentage | Reason for Change | | :--- | :--- | :--- | | Interest Receivable | -98.09% | Due to receipt of interest accrued in prior years from BT projects | | Long-term Receivables | -100.00% | Due to repayment of loans from BT projects | | Employee Compensation Payable | -81.03% | Due to payment of performance wages and bonuses accrued in the previous year | | Other Current Liabilities | -60.28% | Due to reduction in taxes and surcharges accrued from BT project tax payments | Income Statement Key Item Changes and Reasons | Item | Change Percentage | Reason for Change | | :--- | :--- | :--- | | Operating Revenue | -21.94% | Due to reduced income from BT projects and plant extraction business | | Operating Costs | -34.78% | Due to decreased revenue and improved gross margin of BT projects | | Selling Expenses | 58.25% | Due to increased expenses from introducing market sales talent in subsidiaries | | Financial Expenses | -51.08% | Due to reduction in bank loans | | Income Tax Expense | 109.48% | Due to increase in total profit | Cash Flow Statement Key Item Changes and Reasons | Item | Change Percentage | Reason for Change | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 110.44% | Due to **145 million yuan** in repayments from BT projects | | Net Cash Flow from Financing Activities | -87.96% | Due to **200 million yuan** in temporary borrowings for BT projects in the prior year period | [Progress of Significant Matters](index=7&type=section&id=III.%20II.%20Progress%20of%20Significant%20Matters%2C%20Their%20Impact%2C%20and%20Analysis%20of%20Solutions) The company disclosed progress on two significant matters: the BT project has cumulatively completed approximately **1.62 billion yuan** in output value and received **1.2774 billion yuan** in repurchase payments, contributing **23.25 million yuan** in net profit in Q1, and the plan to raise no more than **760 million yuan** through a rights issue has been approved by the shareholders' meeting - BT project progress: As of March 31, 2018, the project has cumulatively completed an engineering output value of approximately **1.62 billion yuan** and cumulatively received repurchase payments of **1.2774 billion yuan**; in Q1 2018, the project achieved a net profit of **23,248,675.88 yuan**[18](index=18&type=chunk) - Rights issue plan: The company plans to raise a total of no more than **760 million yuan** through a rights issue, with the relevant proposal approved at the 2017 Annual Shareholders' Meeting on April 19, 2018[19](index=19&type=chunk) [2018 Half-Year Performance Forecast](index=8&type=section&id=III.%20IV.%20Forecast%20of%20Operating%20Performance%20for%20January-June%202018) The company forecasts net profit attributable to shareholders for the first half of 2018 to be between **64.23 million yuan and 99.91 million yuan**, representing a year-on-year change of **-10% to 40%**, driven by increased plant extraction business from new factory capacity and contributions from completed BT projects 2018 January-June Performance Forecast | Item | Data | | :--- | :--- | | Net Profit Attributable to Shareholders Change Range | -10.00% to 40.00% | | Net Profit Attributable to Shareholders Range (10,000 yuan) | 6,422.88 to 9,991.14 | | Net Profit Attributable to Shareholders in 2017 Same Period (10,000 yuan) | 7,136.53 | - Reasons for performance change: With the gradual release of new factory capacity, the plant extraction business is expected to achieve year-on-year growth in revenue and profit; simultaneously, the progressive completion and acceptance of various unit projects under the BT project will also contribute significant earnings[21](index=21&type=chunk) [Other Compliance Matters](index=8&type=section&id=Other%20Significant%20Matters) During the reporting period, the company had no overdue unfulfilled commitments, no illegal external guarantees, no non-operating fund occupation by controlling shareholders or their related parties, and no investor relations activities - The company had no overdue unfulfilled commitments from the actual controller, shareholders, related parties, acquirers, or the company itself during the reporting period[20](index=20&type=chunk) - The company had no illegal external guarantees during the reporting period, nor any non-operating fund occupation by controlling shareholders or their related parties[22](index=22&type=chunk)[23](index=23&type=chunk) - The company did not host any investor surveys, communications, or interviews during the reporting period[24](index=24&type=chunk)
莱茵生物(002166) - 2017 Q4 - 年度财报
2018-03-29 16:00
桂林莱茵生物科技股份有限公司 2017 年年度报告全文 桂林莱茵生物科技股份有限公司 2017 年年度报告 2018 年 03 月 1 桂林莱茵生物科技股份有限公司 2017 年年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连 带的法律责任。 公司负责人秦本军、主管会计工作负责人郑辉及会计机构负责人(会计主管 人员)张为鹏声明:保证年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中涉及公司未来计划等前瞻性陈述,公司声明该计划不构成公司对 投资者的实质承诺,请投资者及相关人士对此保持足够的风险认识,理解计划、 预测与承诺之间的差异。 本公司敬请广大投资者认真阅读本年度报告全文,并特别注意公司存在的 政策风险、宏观经济风险、市场风险、管理风险、原材料采购风险、汇率变动 风险等,详细内容见本年度报告"第四节 经营情况讨论与分析"之"九、公司未 来发展的展望"中阐述的公司可能面对的风险因素。 公司经本次董事会审议通过的利润分配预案为:以公司现有总股 ...
莱茵生物(002166) - 2017 Q3 - 季度财报
2017-10-24 16:00
桂林莱茵生物科技股份有限公司 2017 年第三季度报告正文 证券代码:002166 证券简称:莱茵生物 公告编号:2017-075 桂林莱茵生物科技股份有限公司 2017 年第三季度报告正文 1 桂林莱茵生物科技股份有限公司 2017 年第三季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人秦本军、主管会计工作负责人秦本军及会计机构负责人(会计主 管人员)张为鹏声明:保证季度报告中财务报表的真实、准确、完整。 2 桂林莱茵生物科技股份有限公司 2017 年第三季度报告正文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产(元) | 3,011,219,537.31 | | 2,431,269,694.87 | 23.8 ...
莱茵生物(002166) - 2017 Q2 - 季度财报
2017-08-15 16:00
桂林莱茵生物科技股份有限公司 2017 年半年度报告全文 桂林莱茵生物科技股份有限公司 2017 年半年度报告 2017 年 08 月 1 桂林莱茵生物科技股份有限公司 2017 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的 真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和 连带的法律责任。 公司负责人秦本军、主管会计工作负责人周庆伟及会计机构负责人(会计主 管人员)张为鹏声明:保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中涉及公司未来计划等前瞻性陈述,公司声明该计划不构成公司对 投资者的实质承诺,请投资者及相关人士对此保持足够的风险认识,理解计划、 预测与承诺之间的差异。 公司计划不派发现金红利,不送红股,不以公积金转增股本。 2 | 目录 | | --- | | 第一节 重要提示、目录和释义 2 | | --- | | 第二节 公司简介和主要财务指标 6 | | 第三节 公司业务概要 9 | | 第四节 经营情况讨论与分析 12 | | 第五节 重要事项 24 | ...
莱茵生物(002166) - 2017 Q1 - 季度财报
2017-04-26 16:00
桂林莱茵生物科技股份有限公司 2017 年第一季度报告正文 证券代码:002166 证券简称:莱茵生物 公告编号:2017-016 桂林莱茵生物科技股份有限公司 2017 年第一季度报告正文 桂林莱茵生物科技股份有限公司 2017 年第一季度报告正文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人秦本军、主管会计工作负责人周庆伟及会计机构负责人(会计主 管人员)张为鹏声明:保证季度报告中财务报表的真实、准确、完整。 桂林莱茵生物科技股份有限公司 2017 年第一季度报告正文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否因会计政策变更及会计差错更正等追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入(元) | 142,814,856.38 | 109,095,510.09 | 30.91% | ...